Click to return to home page

About IMS Global Services

IMS provide the answers

IMS provide Market Insight

Industry events, conferences and links

Our complete product range

Latest news and press releases

Addresses, phone numbers and emails

 

 



An in-depth environmental analysis of the world's leading pharmaceutical markets.


The Market Prognosis Series comprises 4 regional analyses, each providing unique insight into the healthcare and pharmaceutical environment. For each country in every region, primary research is conducted with industry experts and combined with IMS HEALTH sales information to develop five-year forecasts.


The Market Prognosis Series provides 5 year forecasts at country level, bringing insight into the macro-environmental issues that could affect future development of the country and the impact on its healthcare system.

Included in the service;

5 year forecasts - developed by combining quantitative and qualitative methodologies.

Regional coverage - four regions comprising over 36 countries
- Market Prognosis International - Australia, Belgium, Canada, France, Germany, Italy, Japan, South Africa, Spain, Switzerland, UK, USA
- Market Prognosis Asia - China, Hong Kong, India, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand.
- Market Prognosis Latin America - Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela
- Market Prognosis Central & Eastern Europe - Bulgaria, Czech Republic, Hungary, Poland, Slovakia, Slovenia, Turkey .
- Market Market Prognosis - summary information and 5 year forecasts for over 230 countries worldwide

Macroeconomic and healthcare issues covered - each country report contains
- Economic and Political trends
- Cost containment, pricing, reimbursement and regulatory issues,
- Business environment,
- Market size and 5 year forecasts at country and therapy class level,
- Interviews with experts in each country

International standards - able to compare across countries and drill down into specific country

Annual Updates - available from January onwards


Market Prognosis Series was established in 1980 and is renowned for providing comprehensive, independent strategic forecasting. The service is widely used by global, multinational and national pharmaceutical companies to assist with their annual planning process.


Market Prognosis reports can be purchased as full subscriptions which include Executive Summary, Regional Overview, Pocket Prognosis interim forecast updates which are available as intranet versions or stand-alone CD-ROM (price upon application).

Individual country reports are also available (price upon application).

For further information - click here...



Request further information



Products and Services

Company and Market Studies products:

IMSCompany Profiles

IMS Company Search

IMS
Market Prognosis


Issue Studies


 

Navigate:

Products and Services

Home Page